Evidence map›Paper›PMID 37469611›Full record

ArticleEncephalitis (Seoul, Korea)2022

Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report.

Seondeuk Kim, Seon-Jae Ahn, Han Sang Lee, Woo-Jin Lee, Jangsup Moon, Jin Kyun Park, Kon Chu

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Encephalitis (Seoul, Korea), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Seondeuk KimDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Seon-Jae AhnDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Han Sang LeeDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Woo-Jin LeeDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Jangsup MoonDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Jin Kyun ParkDivision of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kon ChuDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0001-5863-0302
Seoul National University Hospital · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Takayasu arteritis (TAK) is a systemic vasculitis involving large arteries. Reports of direct central nervous system (CNS) involvement in TAK are extremely rare in the literature. In addition, treatment for direct involvement has not been reported. Herein, we describe a case of encephalitis in a TAK patient who presented with fever and headache at the first attack, then cognitive impairment at the second attack. The patient improved with rituximab and especially infliximab. These findings indicate the usefulness of rituximab and infliximab to treat the direct CNS manifestations in TAK.

Indexed as

Central nervous systemEncephalitisTakayasu arteritis

Identifiers

PMID37469611
PMCPMC10295906
OpenAlexW3203274899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.